Kelly W. Burak, MD, FRCPC, MSc (Epid) | Authors

Candidacy for Sorafenib in HCC Patients: Is There a Slippery Slope

March 17, 2011

In North America, hepatocellular carcinoma (HCC) is one of only a few malignancies with an increasing incidence in recent years.[1]